Acadia Pharmaceuticals Inc.
Overview
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company's leading product is NUPLAZID, approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
Therapeutic areas
Central Nervous System DisordersPsychiatric Disorders
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Acadia Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.